87 related articles for article (PubMed ID: 30613582)
1. Tumor inactivation of E-cadherin: a new tool for breast cancer treatment?
Corso G; Bonanni B; Veronesi P
Ann Transl Med; 2018 Nov; 6(Suppl 1):S6. PubMed ID: 30613582
[No Abstract] [Full Text] [Related]
2. E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.
van Horssen R; Hollestelle A; Rens JA; Eggermont AM; Schutte M; Ten Hagen TL
Breast Cancer Res Treat; 2012 Nov; 136(2):365-77. PubMed ID: 23053649
[TBL] [Abstract][Full Text] [Related]
3. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
[TBL] [Abstract][Full Text] [Related]
4. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
Hajra KM; Ji X; Fearon ER
Oncogene; 1999 Dec; 18(51):7274-9. PubMed ID: 10602481
[TBL] [Abstract][Full Text] [Related]
5. Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer.
Hornsveld M; Tenhagen M; van de Ven RA; Smits AM; van Triest MH; van Amersfoort M; Kloet DE; Dansen TB; Burgering BM; Derksen PW
Cell Death Differ; 2016 Sep; 23(9):1483-92. PubMed ID: 27035620
[TBL] [Abstract][Full Text] [Related]
6. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
8. Arf6 regulates EGF-induced internalization of E-cadherin in breast cancer cells.
Xu R; Zhang Y; Gu L; Zheng J; Cui J; Dong J; Du J
Cancer Cell Int; 2015; 15(1):11. PubMed ID: 25678857
[TBL] [Abstract][Full Text] [Related]
9. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
Pan Y; Li J; Zhang Y; Wang N; Liang H; Liu Y; Zhang CY; Zen K; Gu H
Sci Rep; 2016 May; 6():25798. PubMed ID: 27174021
[TBL] [Abstract][Full Text] [Related]
10. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
12. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.
Oesterreich S; Deng W; Jiang S; Cui X; Ivanova M; Schiff R; Kang K; Hadsell DL; Behrens J; Lee AV
Cancer Res; 2003 Sep; 63(17):5203-8. PubMed ID: 14500345
[TBL] [Abstract][Full Text] [Related]
14. Expression of insulin-like growth factor-1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes.
Spiliotaki M; Mavroudis D; Kokotsaki M; Vetsika EK; Stoupis I; Matikas A; Kallergi G; Georgoulias V; Agelaki S
Mol Oncol; 2018 Jan; 12(1):21-32. PubMed ID: 28766847
[TBL] [Abstract][Full Text] [Related]
15. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
16. Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
Hollestelle A; Elstrodt F; Timmermans M; Sieuwerts AM; Klijn JG; Foekens JA; den Bakker MA; Schutte M
Breast Cancer Res Treat; 2010 Jul; 122(1):125-33. PubMed ID: 19763817
[TBL] [Abstract][Full Text] [Related]
17. Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.
Yamashita N; Tokunaga E; Iimori M; Inoue Y; Tanaka K; Kitao H; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2018 Oct; 18(5):e1003-e1009. PubMed ID: 29526677
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the value of GATA3 combined with E-cadherin in the diagnosis of breast cancer.
Luo M; Huang Y; Huang J; Huang S; Wei L; Zhang Y; Zhang Z
J BUON; 2019; 24(3):1038-1044. PubMed ID: 31424658
[TBL] [Abstract][Full Text] [Related]
19. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
